Back to results
US 2017/0290807 A1Published application
Pharmaceutical film composition
AssigneesShilpa Medicare Limited, Nu Therapeutics Pvt Ltd
InventorsNAVNEET MUNDADA, RITESH VINOD BIRLA, BADRINATH ALLAMPALLI, AKSHAY KANT CHATURVEDI
Life of this patent
Estimating the term…
Abstract
The present invention relates to Film Compositions of Ondansetron or its pharmaceutically acceptable salt thereof, which dosage forms are useful for the treatment of various medical conditions.
Claims10
A pharmaceutical film composition comprising:
- a) Ondansetron or its pharmaceutically acceptable salt thereof;
- b) water-soluble polymer mixture consisting essentially of combination of hydrophillic cellulosic polymers, maltodextrin and polyethylene oxide;
- c) a plasticizer;
- d) at least any one of the excipients selected from Colorants, flavouring agents, sweeteners and ion-exchange resins.
1 more element
A process for preparing pharmaceutical film composition comprising:
- a. Providing a solution of Ondansetron hydrochloride in purified water,
- b. Adding Ion exchange resins and sweeteners into step (a) solution followed by Polyethylene oxide addition;
- c. Add Maltodextrin into step (b) solution;
- d. Optionally adding flavours into step (c) solution;
- e. Preparing separately an aqueous dispersion of hydrophillic cellulosic polymers;
- f. Transferring the dispersion of step (e) into step (d) solution;
- g. Homogenizing the solution in step (f);
- h. Adding plasticizers into step (g) solution, followed by dispersing colors and flavours;
- i. Obtaining the film composition onto a polyester film.
6 more elements
(canceled)
A pharmaceutical film composition comprising Ondansetron or its pharmaceutically acceptable salt thereof, wherein film having a surface area of greater than 7 cm2.
Dependencies are inferred from the claim text.